ABVC BioPharma Inc (ABVC)
1.07
+0.01
(+0.94%)
USD |
NASDAQ |
May 17, 16:00
1.05
-0.02
(-1.87%)
After-Hours: 20:00
ABVC BioPharma Total Long Term Debt (Quarterly): 1.469M for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.469M |
| September 30, 2023 | 2.506M |
| June 30, 2023 | 4.182M |
| March 31, 2023 | 4.109M |
| December 31, 2022 | 1.894M |
| September 30, 2022 | 1.866M |
| June 30, 2022 | 1.574M |
| March 31, 2022 | 1.791M |
| December 31, 2021 | 1.64M |
| September 30, 2021 | 1.928M |
| June 30, 2021 | 4.578M |
| March 31, 2021 | 4.557M |
| December 31, 2020 | 4.710M |
| September 30, 2020 | 2.550M |
| June 30, 2020 | 4.064M |
| March 31, 2020 | 4.120M |
| December 31, 2019 | 4.040M |
| September 30, 2019 | 3.762M |
| June 30, 2019 | 3.127M |
| March 31, 2019 | 3.235M |
| December 31, 2018 | 0.80M |
| September 30, 2018 | 0.55M |
| June 30, 2018 | 0.55M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 2.05M |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.007M |
| March 31, 2015 | 0.007M |
| December 31, 2014 | 0.007M |
| September 30, 2014 | 0.007M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 1.116M |
| June 30, 2012 | 1.020M |
| March 31, 2012 | 0.8585M |
| December 31, 2011 | 1.094M |
| September 30, 2011 | 1.150M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
1.469M
Minimum
Dec 2023
4.710M
Maximum
Dec 2020
3.077M
Average
3.127M
Median
Jun 2019
Total Long Term Debt (Quarterly) Benchmarks
| NeuBase Therapeutics Inc | -- |
| Sutro Biopharma Inc | 0.00 |
| Reviva Pharmaceuticals Holdings Inc | -- |
| Flora Growth Corp | 1.931M |
| Journey Medical Corp | 14.68M |